Filed 30 October 2026; quarter ended 26 September · Primary source: financial statements, foundry external revenue, equity/escrow, debt, minority interests, substrate commitments, Classiq and fab disruption. Printed pages 3–6, 9–15, 19–24, 31–35 and 43–44; PDF pages are two higher.
https://www.intc.com/filings-reports/quarterly-reports/content/0000050863-26-000191/0000050863-26-000191.pdfWatchlist - above the conditional 20% entry ceiling
The investment decision
At $59.97, our base illustrates a -2.8% annual return over five model years despite $100bn of sales and a 23% economic operating margin in 2031. The conditional 20% entry ceiling is $20.91; a separate cash-flow cross-check is $12.56. Intel does not qualify for a new model-portfolio entry at this reference price.
Edition update. New coverage using September-quarter 2026 results and October disclosures. Primary filings and remarks are distinguished from Capital Thesis assumptions; prior company reports and existing portfolio positions are unchanged.
The stock fell; the underwriting hurdle did not
Reference price USD 59.97 on 2026-11-02. Intel Corporation common stock trades on Nasdaq as INTC. The regular close fell from $92.07 on 29 October to $65.76 on 30 October and $59.97 on 2 November: 34.9% over two trading sessions. A price decline changes the purchase cost; it does not establish a discount to durable earnings. [S3]
Our view is watchlist, with no new model-portfolio admission. Server demand, useful output per wafer and operating profitability have improved. The counterweight is a renewed investment cycle, PC weakness and an external foundry business that has not yet demonstrated recurring scale. The base case assumes substantial success and still produces a modest negative five-year return at this quote.
The price implies a $318.74bn common-stock market value using 5.315bn shares, before remaining escrow and employee claims. Our broader 5.505bn economic-share proxy implies $330.13bn. The difference matters when investors extrapolate historical EPS or per-share targets across a much larger capital base. These are dated model comparisons, not live market capitalizations. [S1] [S3]
Data cut-off is 3 November 2026 Sydney. September-quarter results, the October results and commitment disclosures, and the latest completed US close are available. No refreshed provider consensus, complete independent yield dataset or customer-by-customer foundry orderbook was obtained. The model is an independent conditional underwrite; it is not consensus and does not assign probabilities. Evidence confidence is high for reported figures and materially lower for the long-term operating path.
Two businesses share one capital-intensive production system
Intel Products sells processors and related platforms. Client Computing and Physical AI Group serves PCs and adjacent devices; Data Center and AI serves servers, including purpose-built silicon. Intel Foundry develops process technology, manufactures wafers and supplies packaging/test services. The key economic constraint is sellable chips, not simply installed wafer capacity. Defects, cycle time, packaging supplies and the mix of products determine usable output and unit costs. [S1] [S6]
A larger factory can lower fixed cost per good chip when it is filled with profitable demand. The same factory creates under-absorption and cash strain when client demand falls or output cannot pass the remaining packaging and substrate bottlenecks. More server demand therefore does not automatically translate into more delivered revenue. Both technical execution and supply-chain investment are necessary.
Intel’s installed x86 ecosystem, customer software compatibility, packaging capabilities and US manufacturing footprint are assets. They do not remove competition from AMD, Arm-based server alternatives, custom accelerators or established foundries. Customers must see competitive performance, cost and reliable schedules before committing designs. The PDK is a design-enablement milestone; it is not a revenue contract.
Management reports improved Intel 3/18A yields and cycle times, 18A-P progress and a 14A 0.9 PDK released in October. These are meaningful execution claims, but we have no independently measured absolute yield, customer minimum volume or full project return series. We do not assume that government backing or strategic shareholder participation guarantees a commercial return. [S5] [S6]
The quarter improved, but the next-quarter bridge is weaker
| Metric | Q3 2025 | Q3 2026 | Interpretation |
|---|---|---|---|
| Revenue | $13.653bn | $16.513bn | +20.9%; actual consolidated sales |
| GAAP gross margin | 38.2% | 43.0% | Improved costs and product mix |
| GAAP operating profit | $0.683bn | $2.522bn | Real operating improvement |
| Intel net income | $4.063bn | $3.320bn | Non-operating items complicate comparison |
| GAAP diluted EPS | $0.90 | $0.60 | Share growth and escrow adjustment matter |
| Adjusted diluted EPS | $0.23 | $0.52 | Excludes SBC and other specified adjustments |
DCAI revenue rose about 78% to $7.3bn while client revenue fell about 5% to $8.1bn. Management attributes the server acceleration to stronger output and broad customer demand. For the following quarter, revenue guidance is $15–16bn, with a $15.5bn midpoint below Q3. Adjusted gross margin is guided to 38% versus 44.1% in Q3; adjusted EPS is $0.25 versus $0.52. These are management forecasts, not reported Q4 results. [S2] [S5] [S6]
The company expects client revenue to decline more than 20% sequentially as memory cost/availability and customer inventory adjustment pressure PCs. DCAI is expected to grow in the mid-teens. Lower revenue against a fixed factory cost base and a stronger purpose-built-silicon mix pressure consolidated margin even if server sales rise. The improvement in one segment does not cancel the cost structure of the other. [S6]
A mid-October accident at Fab 28 caused a manufacturing stoppage. Management’s early Q4 guide includes approximately $300m of revenue impact and two percentage points of gross-margin pressure. The filing says overall remediation costs, production effects and insurance recovery cannot yet be reliably estimated, with effects expected into H1 2027. A stated expected restart date is not proof that operations resumed; we do not assert a confirmed restart. [S1] [S6]
Internal revenue is not evidence of outside foundry adoption
| Q3 2026 foundry measure | USD bn | Meaning |
|---|---|---|
| Segment revenue | 6.697 | Includes transfers to Intel businesses |
| External revenue | 0.411 | Only 6.1% of foundry segment sales |
| Internal revenue, derived | 6.286 | Eliminated on consolidation |
| Operating loss | −1.853 | Still economically loss-making |
The external revenue increase was primarily driven by a non-recurring customer program. Nine-month external revenue also reflects Altera becoming an outside customer after its deconsolidation. Neither comparison is a clean measure of a broad, recurring new-customer ramp. Adding $6.697bn of foundry segment sales to Intel Products would double-count most of the business. [S1] [S6]
The investment case needs outside customers that pay attractive prices across repeat production programs, not just internal wafer transfers, design discussions or a one-off program. Better yields reduce cost, but product qualification, software/design enablement, timing and capacity utilization determine whether that improvement becomes cash. The core model counts only external foundry sales in group revenue.
Base external foundry revenue reaches $6bn in 2031, versus $0.878bn in the first nine months of 2026. That is already an ambitious commercialization assumption. The bull reaches $12bn; the bear only $2.5bn. These are house paths, not signed orders or management commitments. Internal foundry economics also improve through the assumed consolidated margin; they are not valued as a separate profit pool.
Cash conversion is better than GAAP loss, weaker than simple free cash flow
| Nine months to 26 September 2026 | USD bn | Treatment |
|---|---|---|
| Reported operating cash flow | 13.184 | Includes working-capital timing and SBC add-back |
| Cash PPE in investing | −10.216 | Cash paid for equipment |
| Cash PPE in financing | −1.618 | Equipment with extended payment terms |
| Finance-lease principal | −0.951 | Another financing cash outflow |
| Specified residual | 0.399 | Before grants, partner flows, acquisitions and award economics |
| Reported share-based compensation | 1.894 | Real employee compensation, not free owner cash |
The commonly quoted CFO-minus-investing-capex number is $2.968bn. It omits $2.569bn of equipment/lease cash classified in financing. Subtracting those payments leaves $399m, not $3bn. Our cash residual is a defined analytical measure, not Intel’s adjusted free cash flow and not distributable owner earnings. Company-adjusted measures also incorporate certain incentives and partner contributions. [S1] [S2]
CFO benefited from customer deposits, while inventories, receivables and supplier prepayments absorbed cash. Incentives and capital partners can fund assets, but their timing, conditions and economic claims must be considered. A financing payment should not vanish from an owner-cash analysis merely because accounting classifies it outside investing activities. [S1]
GAAP earnings are also distorted: the quarter contains an approximately $1.0bn gain from revaluing government escrow-share obligations, while the first nine months contain a $12.6bn loss from that same mechanism. Those mark-to-market movements are not current operating cash flows. We exclude them from recurring earnings and include the associated shares in the denominator, rather than subtracting the derivative liability again as cash debt. [S1]
Forward economic operating margins retain a 3%-of-sales employee-award cost paid in cash. That is below the current nine-month reported SBC/revenue ratio of about 4.1%, so it is itself a normalization assumption. The model neither adds the expense back as free cash nor grants free future shares. Existing employee claims are included separately in opening economic shares.
A large cash balance comes with debt, partners and new commitments
| September / subsequent disclosed item | USD bn | How the model handles it |
|---|---|---|
| Cash plus short-term investments | 54.005 | Reported liquidity; restricted cash excluded |
| Debt carrying balance | 50.134 | Interest plus contractual principal payments |
| August common-equity net proceeds | 22.617 | Already in cash; not a future inflow |
| Remaining NCI book equity | 16.642 | Not a cash-debt proxy; earnings/distributions modeled |
| October substrate agreements | 5.3–6.1 | 5.7 midpoint prepayment schedule |
| Classiq acquisition price / maximum contingent | 1.900 / 0.350 | Conservative 2.25 cash reserve |
| Revolver capacity from 1 October | 15.000 | Undrawn; availability/refinancing conditional |
Intel reacquired Apollo’s Ireland factory interest for $14.2bn in April; that historic payment is already reflected in September cash. Arizona SCIP retains 49% outside ownership and minimum-production obligations. Mobileye and IMS also have minority owners. Group cash and EBIT do not belong wholly to Intel common holders. Management expects approximately $1.1bn of NCI income in both 2027 and 2028, which anchors our early forecast deductions. [S1] [S6]
The substrate agreements are estimated to require $3.3bn by the end of 2027, but some terms are not final. We assume $3.3bn in 2027 and $2.4bn in 2028. Because these are supply prepayments, $1.4bn per year is released in 2029–31 against materials already expensed in operating profit; otherwise we would charge the same purchase twice. A $1.5bn residual has no separate exit recovery value. Actual arrangements may differ materially. [S1]
Classiq is not yet a completed acquisition. The agreement allows cash or stock and contingent consideration; our $2.25bn all-cash 2027 assumption is conservative on cash and does not assume quantum revenue. It should be updated when closing and payment terms become observable. The model also reserves $4bn of net cash use between September and its FY2027 opening date, rather than carrying all September liquidity forward untouched. [S1]
The base has $30bn of annual cash capex in 2027 and 2028 before easing to $25bn in 2031. Management guides 2026 gross capex to $20bn and says 2027 will be up strongly; our cash path is not company guidance. It includes equipment and finance-lease principal, assumes no fresh grants or capital-partner contributions, and embeds operating-lease cost in EBIT. [S6]
The per-share bridge must survive financing and dilution
| Economic share input | Billions | Basis |
|---|---|---|
| Common shares | 5.315 | Outstanding 23 October |
| All remaining government escrow shares | 0.132 | Included once, contingent and non-contingent |
| Legacy employee-award proxy | 0.058 | Q3 diluted increment 63m less 5m escrow |
| Opening economic denominator | 5.505 | House proxy, not reported spot diluted shares |
The 242m shares sold in August are already in the 5.315bn count. The $23bn gross financing was not sales and did not create an equal amount of new operating earnings. The Q4 5.44bn diluted-share guide is weighted-average EPS guidance and is not a complete claim inventory. Our 5.505bn denominator conservatively includes all 132m unreleased escrow shares and a proxy for legacy employee awards. It is not an exact treasury-stock calculation at today’s share price. [S1] [S6]
Up to 241m government warrants at a $20 strike become exercisable if Intel ceases majority ownership of its foundry. Our cases retain majority ownership, so the warrants are not unconditional dilution. A separate approximate net-share exercise sensitivity reduces the base terminal price to $50.68. A divestment could also change operating economics, taxes and capital needs; the share-only sensitivity is not a full separation case. [S1]
Scheduled debt principal is paid annually. If cash would fall below $10bn, the model borrows up to a $15bn incremental cap with a 1% issue fee; a further shortfall issues shares at the explicit case price with a 2% fee. Additional debt is assumed refinanced when facilities mature, with another 1% fee in 2029 and 2031. These are available-funding assumptions, not evidence of lender approval. Interest uses opening balances; year-end borrowing starts accruing modeled interest the following year. Intra-year liquidity can be tighter.
Base incremental borrowing peaks at $0.61bn. The bear needs $9.79bn. Primary cases need no new common-equity funding beyond existing claims, but the capex stress can require it. Future employee awards are cash-settled instead of increasing shares. The report therefore does not claim that dilution has disappeared; it makes the chosen compensation and financing convention explicit.
A recovery is already built into the base case
| Base house forecast, USD bn | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|
| Client revenue | 28.0 | 29.0 | 30.0 | 31.0 | 32.0 |
| Data-center revenue | 37.0 | 41.0 | 46.0 | 52.0 | 58.0 |
| External foundry revenue | 1.5 | 2.5 | 4.0 | 5.0 | 6.0 |
| Other external revenue | 3.0 | 3.5 | 4.0 | 4.0 | 4.0 |
| Consolidated revenue | 69.5 | 76.0 | 84.0 | 92.0 | 100.0 |
| Economic EBIT margin | 10% | 14% | 18% | 21% | 23% |
| Cash capex | 30.0 | 30.0 | 27.0 | 26.0 | 25.0 |
| Recurring earnings after interest/tax/NCI | 2.49 | 5.60 | 9.11 | 12.36 | 15.21 |
| Ending cash | 26.93 | 12.28 | 10.00 | 13.85 | 22.64 |
| Ending debt | 46.31 | 43.13 | 40.46 | 37.71 | 34.96 |
The $61.718bn FY2026 anchor combines reported nine-month sales and the Q4 guidance midpoint; it is an estimate, not a reported full year. The base reaches $100bn in 2031, approximately 10% annual growth from that anchor. Data-center revenue doubles from roughly the current annualized run rate; client revenue stabilizes and recovers; outside foundry contracts become recurring. Intel has to deliver all three while improving consolidated operating margin to 23% after employee-award costs.
The base 20% cash tax rate, depreciation schedule and minority-income growth are house assumptions. Cash capex exceeds depreciation even at the end of the forecast, so the turnaround is not made artificially cash-rich by equating replacement spending with a low accounting charge. No share repurchases, dividends or speculative proceeds from selling major assets are assumed.
The bull reaches $140bn and 28% economic EBIT margin, supported by $84bn of data-center, $40bn of client and $12bn of external foundry sales. The bear still has $70bn revenue and a 12% margin; shareholder losses arise because capital intensity and debt servicing leave little recurring earnings, not because all revenue disappears. Worse execution, funding failure or shareholder dilution can cause outcomes below our bear, including total loss.
Five-year prices are conditional outcomes, not forecasts with odds
| House case | 2031 sales / EBIT margin | Exit P/E | Terminal equity, bn | Terminal / share | Annual return |
|---|---|---|---|---|---|
| Bear | $70bn / 12% | 12x | $39.68 | $7.21 | -34.5% |
| Base | $100bn / 23% | 18x | $286.49 | $52.04 | -2.8% |
| Bull | $140bn / 28% | 22x | $639.95 | $116.25 | 14.2% |
The terminal P/E applies to recurring income after gross debt interest, cash tax and minority owners, excluding investment interest on cash. We then add only cash above a $10bn operating reserve. Debt is reflected through the principal-payment schedule and recurring interest burden; subtracting the full debt balance again from an already leveraged P/E valuation would double-count it. Minority economics are likewise deducted through earnings/distributions, not through an arbitrary book-value subtraction.
Base terminal equity = $15.213849bn recurring income × 18 + $12.642204bn excess cash = $286.491492bn. Divide by 5.505bn economic shares for $52.04205124. The model retains $34.961bn debt, so the terminal earnings are not debt-free earnings.
Return is ((terminal share value + cumulative cash distributions) / $59.97)^(1/5) − 1. Distributions are zero. The five FY2027–FY2031 periods are a stylized horizon, not a precise fiscal-to-calendar-date IRR. No probabilities are attached; the cases do not represent expected returns.
A comparable unchanged-multiple ranking is omitted. Near-term turnaround earnings are depressed; applying today’s very high price-to-FY2027-house-earnings ratio to mature 2031 profits would manufacture an implausible no-rerating upside. The report remains unranked rather than using that artifact as a cross-company investment score. The source model retains the calculation only as a diagnostic.
An entry hurdle is not intrinsic value
Reference price USD 59.97 on 2026-11-02. The base case models -2.8% annually over 5 years, with terminal wealth per share USD 52.04 and no cash distributions. The conditional 20% annual-return entry ceiling is USD 20.91.
The exact base threshold is $52.042051242981 / 1.2^5 = $20.914533196286; the published ceiling is rounded down to $20.91. At $59.97, Intel is above this threshold and does not qualify for a new model-portfolio position. This rule is a conditional arithmetic screen, not a statement that any price below the ceiling is safe.
The base threshold assumes the stated sales, margins, capex, funding, tax, minority distributions, share treatment and 18x multiple all hold. A falling share price can change financing and employee-compensation economics. The backsolve holds those paths fixed; it is not a self-adjusting financing model.
A separate cash-flow cross-check gives $12.56 per share at a 10.5% discount rate and 2.5% perpetual growth. It discounts operating cash after minority distributions and all modeled investment/prepayment/acquisition cash, then adds opening cash above the $10bn reserve and subtracts opening debt. Year-six cash is $11.868bn. No later prepayment release or repeat acquisition is perpetuated.
The lower DCF is economically informative: early investment absorbs cash, while the earnings-multiple case assumes the market will award 18x mature profits despite continuing capex. Neither method is a verified fair value. The discount rate is a house risk assumption rather than a falsely precise measured WACC; a lower rate or longer high-growth period raises value. We do not average the two methods to hide the gap.
| Base exit P/E only | Terminal / share | Annual return | 20% entry |
|---|---|---|---|
| 12x | $35.46 | -10.0% | $14.25 |
| 15x | $43.75 | -6.1% | $17.58 |
| 18x | $52.04 | -2.8% | $20.91 |
| 21x | $60.33 | 0.1% | $24.25 |
| 24x | $68.62 | 2.7% | $27.58 |
| DCF discount rate / perpetual growth | 1.5% growth | 2.5% growth | 3.5% growth |
|---|---|---|---|
| 9.0% discount | $14.85 | $17.83 | $21.90 |
| 10.5% discount | $10.66 | $12.56 | $15.00 |
| 12.0% discount | $7.71 | $9.01 | $10.60 |
| Full funded sensitivity | Terminal / share | Annual return | Incremental debt peak, bn | New equity gross, bn |
|---|---|---|---|---|
| Base | $52.04 | -2.8% | 0.61 | 0.00 |
| Cash capex +25% every year | $45.09 | -5.5% | 15.00 | 12.19 |
| EBIT margin −3pp every year | $42.25 | -6.8% | 6.35 | 0.00 |
The P/E table holds the funded operating path fixed. The capex/margin stresses instead recompute cash, borrowing, fees, interest and any necessary share issuance. They are not company forecasts. Neither sensitivity proves funds will be available on the assumed terms.
What would change the thesis
| Evidence window | Proof that improves the case | Warning that weakens it |
|---|---|---|
| Next reported quarter; date not verified here | Server shipments convert demand into cash; client inventories normalize | Guide misses, further idle capacity or inventory charges |
| 2027 foundry commercialization | Repeat external programs, paid volume and customer economics | One-off external revenue or engagement claims without production |
| 18A-P / 14A milestones | Reliable yields, qualification and lower delivered-chip costs | Delays, costly rework or capacity built ahead of commitments |
| 2027 capital and supply spending | Cash capex/prepayments match funded utilization gains | Spending outruns output; more equity, borrowing or partner concessions |
| Fab 28 recovery | Confirmed operational restoration and quantified costs/recovery | Persistent disruption or unquantified additional costs |
| Every reporting period | Improving cash after all equipment/lease payments and NCI | Headline adjusted earnings without owner-cash progress |
The next decision is not to predict a daily stock bounce. It is to verify whether the incremental factory and supply-chain dollars earn attractive returns. A sufficiently lower entry price, materially better cash conversion, or credible recurring outside foundry economics could change the conclusion. A new customer logo without disclosed economics is weaker evidence than shipped volume and cash receipts. [S1] [S6]
Scope, source conflicts and model limits
Primary filings control historical figures. SEC and IR copies of the same release are corroborating mirrors, not independent opinions. The prepared remarks contain management views, including large long-term CPU market forecasts; those claims are not imported directly as house revenue. No precise current consensus or independent yield percentage is presented because neither was verified.
Price sources displayed different intraday timestamps and slightly different volumes. We use the completed $59.97 regular close corroborated by Alpaca SIP; volume is not an underwriting input. The release rounds many segment figures, while the filing supplies exact group/foundry amounts. Charts explicitly identify rounded observations. [S3]
This is a transparent operating/cash/debt/share model rather than a full statutory three-statement forecast. It does not forecast every deferred-tax item, pension, litigation contingency, covenant, lease modification, subsidy condition or working-capital account. Balance-sheet access restrictions and contingent financing can make the simplified $10bn cash floor insufficient. Legacy award dilution is a proxy; no exact post-quarter award roll-forward was obtained.
The source-supported actuals are stronger evidence than the five-year forecasts. Scenario multiples, cash-award settlement, margins, acquisition timing, substrate recovery, funding prices and mature cash requirements are assumptions. Severe operating or financing failure can exceed the modeled downside. The report provides a conditional investment framework, not a personal trade instruction.
Financial exhibits
Exact observations accompany every chart. Actuals, management guidance and Capital Thesis assumptions are labelled separately; the chart shapes do not imply probabilities.
Operating recovery is real; cash commitments are the next test
Revenue and GAAP operating profit improved across the latest quarters, but the series does not forecast a smooth continuation.
| Observation | Revenue, rounded actual | GAAP operating profit, rounded actual |
|---|---|---|
| Q4 2025 | 13.7 | 0.6 |
| Q1 2026 | 13.6 | -3.1 |
| Q2 2026 | 16.1 | 1.8 |
| Q3 2026 | 16.5 | 2.5 |
Rounded values from the primary presentation. Q1 operating loss includes restructuring/impairment; intervals are quarterly, not annual. Sources: [S5]
Most foundry sales are internal transfers
The outside-customer number is much smaller and includes a non-recurring program.
| Observation | Internal foundry sales, derived | External foundry sales |
|---|---|---|
| Q3 2025 | 4.203 | 0.032 |
| Q3 2026 | 6.286 | 0.411 |
Segment revenue less external revenue derives internal transfers. Both series share the same quarter basis; transfers eliminate on consolidation. Sources: [S1]
Financing-classified equipment is still a cash cost
CFO less all specified equipment and finance-lease cash payments leaves only $399m before other owner claims.
| Observation | Nine-month cash components |
|---|---|
| Operating cash | 13.184 |
| Investing PPE | -10.216 |
| Financing PPE | -1.618 |
| Lease principal | -0.951 |
| Residual | 0.399 |
First nine months of 2026. Component chart, not a chronological cash path. Excludes grants, partner flows, acquisitions and SBC economics; not company adjusted free cash flow. Sources: [S1]
The base already assumes a substantial turnaround
External consolidated sales grow to $100bn while cash investment remains high.
| Observation | Consolidated revenue | Economic EBIT after award costs | All-in cash capex |
|---|---|---|---|
| 2027E | 69.5 | 6.95 | 30 |
| 2028E | 76 | 10.64 | 30 |
| 2029E | 84 | 15.12 | 27 |
| 2030E | 92 | 19.32 | 26 |
| 2031E | 100 | 23 | 25 |
Capital Thesis assumptions, not guidance. Internal foundry transfers excluded; margin includes 3%-sales cash employee-award reserve. Sources: [S1] [S6]
Cash and debt both matter to the recovery
Base capital needs consume much of the cash raised before later profits rebuild liquidity.
| Observation | Base ending cash | Base ending debt | Bear ending debt |
|---|---|---|---|
| 2027E | 26.9348 | 46.308 | 46.308 |
| 2028E | 12.2799 | 43.135 | 43.135 |
| 2029E | 10 | 40.4614 | 45.4554 |
| 2030E | 13.852 | 37.7114 | 45.8326 |
| 2031E | 22.6422 | 34.9614 | 44.1338 |
House annual cash/debt roll-forward, with scheduled maturities, interest, conditional refinancing and cash floor of $10bn. Not evidence of borrowing approval. Sources: [S1] [S7]
A lower quote still requires strong execution
The base is below the reference quote despite substantial revenue and margin recovery.
| Observation | Conditional FY2031 price | 2 November reference |
|---|---|---|
| Bear | 7.2081 | 59.97 |
| Base | 52.0421 | 59.97 |
| Bull | 116.2497 | 59.97 |
House scenarios; no probabilities or intermediate price paths. 5.505bn economic shares; no dividends. P/E 12x / 18x / 22x after interest, tax and NCI plus excess cash. Sources: [S1] [S3] [S6]
Three prices answer different questions
The conditional hurdle does not establish fair value, and both sit below the reference price.
| Observation | Dated reference or house calculation |
|---|---|
| Reference close | 59.97 |
| Base 20% entry | 20.91 |
| DCF cross-check | 12.5563 |
Entry is terminal $52.042051/1.2^5 rounded down. DCF 10.5%/2.5%, after minority distributions, minus debt, operating cash reserve excluded. Neither valuation is guaranteed. Sources: [S1] [S3]
Source register and research basis
Evidence checked for this edition on 3 November 2026. Dates below identify source vintages. Company guidance and house scenarios are conditional; source links and the downloadable model allow the assumptions to be inspected.
29 October 2026 · Primary release: actual GAAP/non-GAAP results, reconciliations, business highlights and fourth-quarter guidance.
https://www.intc.com/news-events/press-releases/detail/1786/intel-reports-third-quarter-2026-financial-results2 November 2026 regular close; retrieved 3 November · USD 59.97 close, corroborated by native Alpaca SIP daily bars. Other pages retained intraday/15:59 observations; those are excluded. No after-hours price used.
https://stockanalysis.com/stocks/intc/history/Reviewed 3 November 2026 · Recency check. Latest financial evidence is the 29 October Q3 release and subsequent 10-Q, not a forecast of an unreported quarter.
https://www.intc.com/news-events/press-releases29 October 2026 · Primary presentation. Five-quarter trend charts and guidance; explicitly non-GAAP where labeled. Rounded historical series are retained as rounded, not false precision.
https://d1io3yog0oux5.cloudfront.net/_47986fe477a6ac84fe34efbcbf38dd13/intel/db/887/9273/earnings_presentation/Q3_2026_Earnings_Deck.pdf29 October 2026 · Primary comments, pages 1–7: supply/demand, yields, customer engagement, Q4 bridge, capex and NCI expectations. Statements about future markets and technology are management claims, not independent forecasts.
https://d1io3yog0oux5.cloudfront.net/_47986fe477a6ac84fe34efbcbf38dd13/intel/db/887/9273/prepared_remarks/Q3'26_Prepared_Remarks.pdf23 January 2026 · Historical baseline: debt-maturity schedule, lease conventions, partnership commitments and product risks. Updated by the Q3 filing; old balances are never substituted for September actuals.
https://www.intc.com/filings-reports/annual-reports/content/0000050863-26-000011/0000050863-26-000011.pdf29 October 2026 · SEC mirror corroborates reported results and the forward guidance; same underlying release as S2, not a second independent estimate.
https://www.sec.gov/Archives/edgar/data/50863/000005086326000188/q326earningsrelease.htm